Outlook Therapeutics, Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Outlook Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2023.
  • Outlook Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$13M, a 46.4% decline year-over-year.
  • Outlook Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$43M, a 24.2% increase from 2022.
  • Outlook Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$56.7M, a 4.46% decline from 2021.
  • Outlook Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$54.3M, a 70.7% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$43M +$13.7M +24.2% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-22
2022 -$56.7M -$2.42M -4.46% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-22
2021 -$54.3M -$22.5M -70.7% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-29
2020 -$31.8M +$500K +1.55% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 -$32.3M +$750K +2.27% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2018 -$33M -$17.5M -113% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-19
2017 -$15.5M Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.